NEU 0.85% $15.14 neuren pharmaceuticals limited

The Whens and Whys of Top Biotech M&A Deals, page-44

  1. 1,583 Posts.
    lightbulb Created with Sketch. 329
    I agree with you Turbo. I also noted in Jon's first Q & A timestamp 23.43 regarding the results affecting the licencing decisions he answered "other than greatly improving our confidence and i think hopefully increasing the conficence of others"
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.